Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R Ruffolo

Showing results (111-120 of 230) with videos related to

Pageof 23
Sort By:
European Journal of Pharmacology|September 23, 1987
Inhibition of plasma cholinesterase prevents the dopamine DA-1 receptor mediated renal vasodilation produced by ibopamineA J Nichols, R J Shebuski, R R Ruffolo
Current Opinion in Chemical Biology|July 27, 1999
Apoptosis: a potential target for discovering novel therapies for cardiovascular diseasesT L Yue, E H Ohlstein, R R Ruffolo
Annual Review of Pharmacology and Toxicology|June 3, 2000
Drug discovery in the next millenniumE H Ohlstein, R R Ruffolo, J D Elliott
European Journal of Pharmacology|August 1, 1976
A kinetic analysis of a catechol-specific binding site in the microsomal fraction from the rabbit aortaR R Ruffolo, R L Mccreery, P N Patil
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1986
Alpha adrenoceptor regulation of coronary artery blood flow in normal and stenotic canine coronary arteriesG A Kopia, L J Kopaciewicz, R R Ruffolo
Pharmacology|January 1, 1988
Comparison of the renal and pulmonary hemodynamic effects of fenoldopam, dobutamine, dopamine and norepinephrine in the anesthetized dogR J Shebuski, J M Smith, R R Ruffolo
European Journal of Clinical Pharmacology|January 11, 1990
Hemodynamic differences between carvedilol and labetalol in the cutaneous circulationR R Ruffolo, C F Sauermelch, R N Willette
Fundamental & Clinical Pharmacology|January 11, 1991
The effect of pertussis toxin on alpha 1-adrenoceptor-mediated vasoconstriction by the full agonist, cirazoline, and the partial agonist, (-)-dobutamine, in pithed ratsR R Ruffolo, E D Motley, A J Nichols
Expert Opinion on Investigational Drugs|July 5, 2005
Pharmacology of the angiotensin II receptor antagonist, eprosartanR M Edwards, R R Ruffolo, D P Brooks
Progress in Cardiovascular Diseases|August 26, 1998
Novel mechanisms in the treatment of heart failure: inhibition of oxygen radicals and apoptosis by carvedilolG Feuerstein, T L Yue, X Ma, et al.
Pageof 23

Showing results (111-120 of 230) with videos related to

Sort By:
Pageof 23
European Journal of Pharmacology|September 23, 1987
Inhibition of plasma cholinesterase prevents the dopamine DA-1 receptor mediated renal vasodilation produced by ibopamineA J Nichols, R J Shebuski, R R Ruffolo
Current Opinion in Chemical Biology|July 27, 1999
Apoptosis: a potential target for discovering novel therapies for cardiovascular diseasesT L Yue, E H Ohlstein, R R Ruffolo
Annual Review of Pharmacology and Toxicology|June 3, 2000
Drug discovery in the next millenniumE H Ohlstein, R R Ruffolo, J D Elliott
European Journal of Pharmacology|August 1, 1976
A kinetic analysis of a catechol-specific binding site in the microsomal fraction from the rabbit aortaR R Ruffolo, R L Mccreery, P N Patil
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1986
Alpha adrenoceptor regulation of coronary artery blood flow in normal and stenotic canine coronary arteriesG A Kopia, L J Kopaciewicz, R R Ruffolo
Pharmacology|January 1, 1988
Comparison of the renal and pulmonary hemodynamic effects of fenoldopam, dobutamine, dopamine and norepinephrine in the anesthetized dogR J Shebuski, J M Smith, R R Ruffolo
European Journal of Clinical Pharmacology|January 11, 1990
Hemodynamic differences between carvedilol and labetalol in the cutaneous circulationR R Ruffolo, C F Sauermelch, R N Willette
Fundamental & Clinical Pharmacology|January 11, 1991
The effect of pertussis toxin on alpha 1-adrenoceptor-mediated vasoconstriction by the full agonist, cirazoline, and the partial agonist, (-)-dobutamine, in pithed ratsR R Ruffolo, E D Motley, A J Nichols
Expert Opinion on Investigational Drugs|July 5, 2005
Pharmacology of the angiotensin II receptor antagonist, eprosartanR M Edwards, R R Ruffolo, D P Brooks
Progress in Cardiovascular Diseases|August 26, 1998
Novel mechanisms in the treatment of heart failure: inhibition of oxygen radicals and apoptosis by carvedilolG Feuerstein, T L Yue, X Ma, et al.
Pageof 23